We improve sexual health and wellness through new delivery methods that prioritize clinical integrity and consumer convenience. Our solutions break down screening barriers through discreet patient-tailored individualized digital approaches that complement traditional brick-and-mortar care. In addition to our “test and treat”, point-of-care (POC), molecular diagnostic platform for chlamydia and gonorrhea, two of the most tested for sexually transmitted infections (STIs) globally, we provide a first of its kind, comprehensive digital program that includes evidence-based testing, counseling, treatment, and follow up in order to increase screening and reduce infections.
How does it work?
binx io is a first-of-its-kind, highly sensitive and specific, point-of-care (POC) diagnostic testing platform and is a rapid, qualitative, fully-automated test, designed to be easy to use, and intended for use in POC or clinical laboratory settings, providing the world’s first sample-to-answer result in about 30 minutes for the detection of chlamydia (CT) and gonorrhea (NG)– the two most tested-for STIs globally.
Reach out to us today at firstname.lastname@example.org to learn more.
Contact us today